- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Patent holdings for IPC class A61P 19/08
Total number of patents in this class: 1900
10-year publication summary
|
59
|
90
|
63
|
110
|
132
|
137
|
131
|
147
|
148
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1829 |
31 |
| Alexion Pharmaceuticals, Inc. | 606 |
24 |
| The Regents of the University of California | 18943 |
22 |
| Novartis AG | 11238 |
19 |
| Takeda Pharmaceutical Company Limited | 2961 |
18 |
| Société des Produits Nestlé S.A. | 9672 |
17 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
13 |
| Genzyme Corporation | 1205 |
13 |
| Acceleron Pharma Inc. | 365 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
12 |
| Ascendis Pharma Growth Disorders A/S | 36 |
12 |
| Wisconsin Alumni Research Foundation | 3774 |
11 |
| Megmilk Snow Brand Co., Ltd. | 173 |
11 |
| Ono Pharmaceutical Co., Ltd. | 454 |
11 |
| Shionogi & Co., Ltd. | 914 |
11 |
| AstraZeneca AB | 3042 |
10 |
| Centre National de La Recherche Scientifique | 9632 |
10 |
| Amgen Inc. | 3779 |
10 |
| Osaka University | 3143 |
10 |
| Keros Therapeutics, Inc. | 53 |
10 |
| Other owners | 1613 |